Table 1.
Gene (RefSeq Accession Number) | Listsa | Reason for Highlightb | Identification Methodc | ID Structural Variations | ID Point Mutations | Occurrence of Mutations in EVSd | Truncated Variants in EVS | dN/dS Ratio (#N/#S) | Protein Size | Implication in ID |
---|---|---|---|---|---|---|---|---|---|---|
AGTR2 (NM_000686.4) | L, R, G, E, A | T | 1 | (X; 7) translocation in a female19 | c.402del (p.Phe134Leufs∗5)19 | (see Table S4) | yes (1 F) | 0.731 (19/8) | 363 | highly questionable (already controversial)20–22 |
c.62G>T (p.Gly21Val)19,23 | 10 M, 23 F (htz) | |||||||||
c.971G>A (p.Arg324Gln)19 | 4 M, 24 F (htz) | |||||||||
c.1009A>G (p.Ile337Val)19 | NF | |||||||||
c.157A>T (p.Ile53Phe)24 | NF | |||||||||
c.572G>A (p.Gly191Glu)23 | NF | |||||||||
MAGT1 (IAP) (NM_032121.5) | L, R, G, E | T | 3 | - | c.1028T>G (p.Val311_343Gly)25 | 5 M, 8 F (htz) | yes (1 M) | 0.453 (15/10) | 367 | highly questionable |
NXF5 (NM_032946.2) | L, R, G, A | T | 1 | inv(X)(p21.1;q22) in two males;26,27 deletion disrupting the NXF cluster;28,29 duplication at Xq22.1 disrupting30 and duplicating31NXF5 in one female and one male, respectively | - | - | yes (8 M) | 0.783 (30/11) | 365 | highly questionable |
ZNF674 (NM_001039891.2) | L, R, E, A | T | 1 | deletion encompassing ZNF673, ZNF674, RP2, SLC9Z7, and CHST7 in one male;32 duplication encompassing ZNF673, ZNF674, and CHST733 | c.352G>T (p.Glu118∗)32 | NF | yes (19 M) | 0.750 (28/10) | 581 | highly questionable (already controversial)34 |
c.1235C>A (p.Pro412Leu)32 | NF | |||||||||
c.1028C>T (p.Met343Thr)32 | 49 M, 16 F (hmz), 223 F (htz) | |||||||||
ZNF41 (NM_007130.2) | L, R, G, E, A | M | 1 | (X; 7) translocation disrupting ZNF4135 | c.332C>T (p.Pro111Leu)35 c.73−42A>C (p.?)35 | 2 M, 8 F (htz) | yes (1 M, 1 F) | 0.696 (45/17) | 779 | highly questionable |
5 M, 9 F (htz) | ||||||||||
ZNF81 (NM_007137.3) | L, R, G, E, A | M | 1 | (X; 9) translocation in one female;36 1.3 Mb duplication encompassing >30 genes at Xp11.23–p11.3 in one male;37 335 kb microduplication bearing two other genes at Xp11.2–p11.3 in one male38 | c.536G>A (p.Ser179Asn)36 | NF | yes (1 M) | 0.595 (25/11) | 661 | questionable |
ARHGEF6 (NM_004840.2) | L, R, G, E, A | M | 1 | (X; 21) translocation in one male39 | c.166−11T>C (p.?)39 | 5 M, 13 F (htz) | no | 0.456 (28/18) | 776 | questionable |
ATP6AP2 (NM_005765.2) | L, R, G, E, A | T | 2 | - | c.321C>T (p.Asp107Asp) (affects splicing)40 | NF | yes (1 M) | 0.444 (14/10) | 350 | questionable |
SRPX2 (NM_014467.2) | L, R, G, E, A | M | 2 | - | c.980A>G (p.Asn327Ser)41 | 3 M, 8 F (htz) | no | 0.728 (31/14) | 465 | questionable |
c.215A>C (p.Tyr72Ser)41 | 1 M | |||||||||
ZCCHC12 (SIZN1) (NM_173798.2) | E | M | 3 | - | c.19C>T (p.Arg7Cys)42 | 5 M, 28 F (htz) | no | 0.406 (19/14) | 402 | questionable |
c.1031C>T (p.Thr344Ile)42 | NF | |||||||||
IGBP1 (NM_001551.2) | L, G, E | I | 2 | - | 5′ UTR 2 bp substitution affecting IGBP1 expression43 | not covered | no | 0.487 (19/11) | 339 | never replicated |
KIAA2022 (NM_001008537.2) | L, R, G, E, A | I | 1 | inv(X)(q13;p22) in two related males44 | - | NA | no | 0.441 (54/34) | 1,516 | never replicated |
KLF8 (NM_007250.4) | L, R, G, E | I | 1 | (X; 21) translocation leading to a loss of KLF8 expression in a woman45 | - | NA | no | 0.831 (16/6) | 359 | never replicated |
NLGN3 (NM_181303.1) | L, R, G, E, A | I | 3 | - | c.1411C>T (p.Arg451_471Cys) in two ASD brothers46 | NF | no | 0.209 (17/27) | 848 | never replicated |
ZDHHC15 (NM_144969.2) | L, G, E | I | 1 | (X; 15) translocation leading to a loss of ZDHHC15 expression in a female47 | - | NA | no | 0.628 (17/8) | 337 | never replicated |
ZNF261 (ZMYM3) (NM_201599.2) | R | I | 1 | (X; 13) translocation disrupting ZMYM3 in one female48 | - | NA | no | 0.232 (31/42) | 1,370 | never replicated |
MAOA (NM_000240.3) | L, R, G, E, A | I | 1 | MAOA-MAOB-NDP deletion in subjects with severe ID49 | c.886C>T (p.Gln296∗)50 | NF | no | 0,359 (14/12) | 527 | never replicated |
CCDC22 (NM_014008.3) | - | I | 3 | - | c.49A>G (p.Thr17Ala)51 | NF | no | 0.809 (40/17) | 627 | awaiting replication |
CLIC2 (NM_001289.4) | - | I | 4 | - | c.303C>G (p.His101Gln)52 | NF | no | 0.346 (6/5) | 247 | awaiting replication |
CNKSR2 (NM_014927.3) | - | I | 1 | partial deletion of CNKSR253 | - | NA | no | 0.340 (22/19) | 1,034 | awaiting replication |
FRMPD4 (NM_014728.3) | - | I | 1 | partial duplication of FRMPD454 | - | NA | no | 0.383 (57/46) | 1,322 | awaiting replication |
HCFC1 (NM_005334.2) | - | I | 2 | - | chrX: 152890455A>G55 | NA | no | 0.227 (50/80) | 2,035 | awaiting replication |
c.674G>A (p.Ser225Asn)55 | NF | |||||||||
NAA10 (NM_003491.2) | L | I | 4 | - | c.109T>C (p.Ser37Pro)56 | NF | no | 0.074 (2/8) | 235 | likely in Ogden syndrome but needs further replication in nonsyndromic ID |
c.346C>T (p.Arg116Trp)13 | NF | |||||||||
RPL10 (NM_006013.3) | L, R, G, E, A | I | 3 | - | c.616C>A (p.Leu206Met) (ASD)57 | NF | no | 0.154 (2/4) | 214 | awaiting replication |
c.639C>G (p.His213Gln) (ASD)57,58 | NF | |||||||||
SHROOM4 (NM_020717.3) | L, R, G, E, A | I | 1 | X-autosome translocations in two females;59 Xp11.22 deletion bearing SHROOM4 in one family54 | c.3266C>T (p.Ser1089Leu)59 | NF | yes (1 F) | 0.918 (86/28) | 1,493 | awaiting replication |
c.1422A>G (p.Glu474Glu)59 | NF | |||||||||
HUWE1 (NM_031407.5) | L, R, G, E, A | I | 1 | microduplications encompassing HSD17B10 and HUWE160,61 or HUWE1 alone62 in a total of 16 unrelated families | c.12037C>T (p.Arg4013Trp)61 | NF | no | 0.201 (67/105) | 4,374 | likely |
c.8942G>A (p.Arg2981His)61 | NF | |||||||||
c.12559C>T (p.Arg4187Cys)61 | NF | |||||||||
c.2849T>A (p.Val950Asp) (ASD)63 | NF | |||||||||
PTCHD1 (NM_173495.2) | L | M | 1 | 160 kb deletion leading to a null PTCHD1 in dizygotic ASD twin brothers;64 50–390 kb inherited deletions disrupting PTCHD1 in six ASD male probands;65 90 kb deletion disrupting PTCHD1 in three related ID males;60,66 200 kb deletion in two ID brothers67 | c.517A>G (p.Ile173Val)66 | 2 M, 2 F (htz) | no | 0.366 (29/25) | 888 | likely |
c.583G>A (p.Val195Ile)66 | NF | |||||||||
c.1008_1009delinsTA (p.MetLeu336_337IleIle)66 | NF | |||||||||
c.217C>T (p.Leu73Phe)66 | 1 F (htz) | |||||||||
c.1436A>G (p.Glu479Gly)66 | NF | |||||||||
c.1409C>A (p.Ala470Asp)66 | NF | |||||||||
c.1076A>G (p.His359Arg)66 | NF | |||||||||
SYN 1 (NM_006950.3) | L, R, G, E, A | M | 2 | - | c.1067G>A (p.Trp356∗)68 | NF | no | 0.347 (12/12) | 705 | likely |
c.1663C>T (p.Gln555∗)69 | not covered | |||||||||
c.152C>G (p.Ala51Gly)69 | 11 M, 30 F (htz) | |||||||||
c.1648G>A (p.Ala550Thr)69 | not covered | |||||||||
c.1699A>G (p.Thr567Ala)69 | not covered |
Abbreviations are as follows: L, Lubs et al.;4 R, Ropers et al.;8 G, Greenwood Genetic Center (see Web Resources); E, Emory Genetics Laboratory (see Web Resources); A, Ambry Genetics (see Web Resources); T, truncating variants reported in EVS; M, ID mutations reported in EVS; I, one piece of evidence or study implicating this gene in ID; htz, heterozygous; hmz, homozygous; M, number of males carrying the mutation; F, number of females carrying the mutation; NF, not found; NA, not applicable; N, number of nonsynonymous variants; and S, number of silent variants.
Lists in which genes are included.
Reason why we discuss this gene in the paper.
Approach used for the initial identification, consistent with the information from the text: 1, positional candidate found through rearrangement or CNV; 2, positional candidate located in a linked region; 3, functional candidate; and 4, through exome or X-exome sequencing.
Occurrence of ID mutations in EVS.